Blood Screening Market is estimated to be valued at USD 5.16 billion in 2026 and is expected to reach USD 8.1 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.4% from 2026 to 2033.
| Report Coverage |
Report Details |
| Base Year: |
2025 |
Market Size in 2026: |
USD 5.16 billion |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: |
7.40% |
2033 Value Projection: |
USD 8.1 billion |
The global blood screening market comprises product type categories such as Shack-Hartmann Aberrometers, Tscherning Aberrometers, and Laser Ray Tracing Aberrometers, serving applications including Refractive Surgery, Cataract Surgery, and Corneal Topography. These offerings are adopted across Hospitals and Clinics, Ophthalmic Research Centers, and Diagnostic Laboratories and other areas, where they support improved efficiency, performance, and reliability. Growing adoption across these segments, combined with ongoing product innovation, continues to support expansion of the market.
Market Dynamics:
Rising demand across key application areas, increasing emphasis on efficiency and performance, and continued product innovation are major factors expected to drive growth of the global blood screening market. Expanding adoption among Hospitals and Clinics, and Ophthalmic Research Centers and growing investment in advanced solutions are further supporting market expansion.
For instance, providers are increasingly developing offerings tailored to Refractive Surgery and related applications. Moreover, ongoing research and development, along with the integration of new technologies, is expected to create new growth opportunities for market players over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global blood screening market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Abbott Laboratories, Bio-Rad Laboratories, Inc., Grifols, S.A., F. Hoffmann-La Roche Ltd., Siemens Healthineers, Terumo Corporation, Becton Dickinson and Company, Ortho Clinical Diagnostics, Hologic, Inc., Luminex Corporation, and DiaSorin S.p.A, among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global blood screening market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood screening market.
Detailed Segmentation:
- Global Blood Screening Market, By Product Type (Revenue, USD Bn, 2021 - 2033)
- Shack-Hartmann Aberrometers
- Tscherning Aberrometers
- Laser Ray Tracing Aberrometers
- Dynamic Aberrometers
- Others
- Global Blood Screening Market, By Application (Revenue, USD Bn, 2021 - 2033)
- Refractive Surgery
- Cataract Surgery
- Corneal Topography
- Customized Contact Lens Fitting
- Others
- Global Blood Screening Market, By End User (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Clinics
- Ophthalmic Research Centers
- Diagnostic Laboratories
- Optical Retail Chains
- Others
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Abbott Laboratories*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Bio-Rad Laboratories, Inc.
- Grifols, S.A.
- F. Hoffmann-La Roche Ltd.
- Siemens Healthineers
- Terumo Corporation
- Becton Dickinson and Company
- Ortho Clinical Diagnostics
- Hologic, Inc.
- Luminex Corporation
- DiaSorin S.p.A
"*" marked represents similar segmentation in other categories in the respective section.